Print
Email
Print Edition StoriesMonday, November 30, 2009
Wurzer takes Connecticut Innovations managing director role
By Galen Moore
MHT's Galen Moore: Hiring trends and opportunities
Breaking down the MIT $100K
MHT's Doug Banks: 10 Women to Watch in tech
Connecticut Innovations has appointed a fourth managing director to its deal team, the venture investing arm of the Connecticut state government announced today.
David Wurzer, formerly CFO of Branford, Conn.-based CuraGen Corp. (Nasdaq: CRGN), will source and analyze investment opportunities, lead investments and advise portfolio companies, according to the press release.
Wurzer shepherded CuraGen, a genomics-based drug company, through its 1997 initial public offering of stock, as well as several follow-on public placements. According to Connecticut Innovations’ press release, Wurzer helped the company raise over $700 million during his tenure. CuraGen sold in October to Celldex for $93.5 million.
A quasi-public non-profit, Connecticut Innovations makes equity investments with technology startups located in the Nutmeg State. Recent investments include Optiwind Corp., a developer of wind turbines; Soft Tissue Regeneration Inc. (STR), a developer of anterior cruciate ligament (ACL) treatment; and Continuity Engine Inc., a developer of on-demand regulatory compliance applications.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
